Skip to main content

Month: February 2026

Guardforce AI Announces Extension of Smart Retail Solutions Partnership with Major Global Sportswear Brand

NEW YORK, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) —   Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), an AI-driven technology company providing Agentic AI smart solutions in automation, robotics, and secured logistics, today announced the extension of its partnership to provide smart retail business solutions to the Thailand branch of a renowned global sportswear brand. Under the extended partnership, Guardforce AI acts as an important technology partner in the client’s ongoing national renovation plan. The Company has received the first batch of requests to deploy its smart retail solutions at five additional retail locations in 2026, and one more installation scheduled for 2027. Previously, the Company deployed similar solutions at two of the brand’s locations, and installed AI camera systems across...

Continue reading

Trident Resources Announces Purchase of Additional 4,711 Hectares at the Contact Lake Gold and Greywacke Gold Projects

Vancouver, BC, Feb. 26, 2026 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company” ) is pleased to announce that it has signed a  mineral property purchase and sale agreement dated February 25th, 2026 (the “Agreement”) with Eagle Plains Resources Ltd.(“Eagle Plains” or the “Vendor”) pursuant to which the Company shall acquire up to 100% interest in 7 individual mineral dispositions that total approximately 4,711 hectares (ha) within the La Ronge Gold Belt in Northern Saskatchewan, Canada. Acquisition Highlights:Attractive acquisition price consisting of small cash paymentHighly prospective mineral dispositions that are contiguous with Trident’s core high-grade gold projects of Contact Lake and Greywacke LakeMultiple high priority targets on the newly acquired dispositions that...

Continue reading

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

SEATTLE, Feb. 26, 2026 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 and Fiscal Year 2025 Business HighlightsContinued progress was made in processing and analyzing Tau proteoform samples from collaborators to support platform validation and expanding scientific publications. Externally generated Tau data measured on the Nautilus Voyager™ platform was presented at the World HUPO conference, and collaborators are advancing results toward submission for publication. Further progress was made in the development of a new broadscale assay format including improvements designed to increase probe compatibility, performance, and...

Continue reading

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

– ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues Full-Year 2026 Net Revenue Guidance of $173 to $183 Million and Adjusted EBITDA of $10 to $20 Million CARY, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) — Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced financial results for the three and twelve months ended December 31, 2025, and highlighted recent corporate updates. “As demonstrated in today’s release, we are entering 2026 with exceptional momentum. The fourth quarter delivered the strongest results in the history of Heron’s Acute Care franchise, underscoring the success of the strategic decisions we implemented to unlock the full potential of these assets,” said...

Continue reading

Rackspace Technology Reports Fourth Quarter and Full Year 2025 Results

Fourth Quarter Revenue of $683 million, down 0.4% Year-over-Year; 2025 Revenue of $2,686 million, down 2% Year-over-Year Fourth Quarter Private Cloud Revenue of $241 million, down 10% Year-over-Year; 2025 Private Cloud Revenue of $990 million, down 6% Year-over-Year Fourth Quarter Public Cloud Revenue of $442 million, up 6% Year-over-Year; 2025 Public Cloud Revenue of $1,696 million up 1% Year-over-Year Fourth Quarter Cash Flow From Operating Activities of $60 million; 2025 Cash Flow From Operating Activities of $151 millionSAN ANTONIO, Feb. 26, 2026 (GLOBE NEWSWIRE) — Rackspace Technology, Inc. (Nasdaq: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced results for its fourth quarter and year ended December 31, 2025. Gajen Kandiah, Chief Executive Officer, stated, “Q4 capped a year of meaningful...

Continue reading

Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

Physician Interview Now Available Key HighlightsResponder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company’s peer-reviewed randomized controlled trial. CMS Payment Rate: $300 national Medicare payment rate established, effective January 1, 2026. Physician Perspective: New interview with Gastroenterologist Dr. Dak Patel about inFoods IBS in clinical use now available at https://investors.biomerica.com/events-and-presentations/default.aspxIRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), an innovator in diagnostic-guided therapy, today announced responder analysis results from its ongoing real-world study of inFoods® IBS. The data demonstrates that a majority of...

Continue reading

Inuvo to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on Thursday, March 5th at 4:15 P.M. ET

LITTLE ROCK, Ark., Feb. 26, 2026 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leader in artificial intelligence-driven advertising technology, will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, March 5, 2026. The Company will host a conference call at 4:15 p.m. Eastern Time that same day to discuss the results and provide a business update. Conference Call Details: Date: Thursday, March 5, 2026Time: 4:15 p.m. Eastern Time Toll-free Dial-in Number: 1-800-717-1738International Dial-in Number: 1-646-307-1865Conference ID: 1145199Webcast Link: HERE A telephone replay will be available through Thursday, March 19, 2026. To access the replay, please dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international). At the system prompt, please enter...

Continue reading

Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product

Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced results from a comparative study evaluating the regional nasal deposition profile of its naloxone formulation versus a commercial reference product. The study was conducted at the University of Parma’s Biopharmanet-TEC research center under the scientific supervision of Prof. Fabio Sonvico. The laboratory specializes in the research and development of intranasally administered technologies. The evaluation was performed using a validated silicone nasal cast model (Koken® LM-005) combined with quantitative image analysis. Results demonstrated that Polyrizon’s formulation achieved significantly higher deposition in...

Continue reading

Lifetime Brands Announces Fourth Quarter and Full Year 2025 Financial Results Release Date and Conference Call

~ Management to Participate in the 38th Annual ROTH Conference ~ GARDEN CITY, N.Y., Feb. 26, 2026 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT) (“Lifetime” or the “Company”), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its fourth quarter and full year 2025 financial results before market open on Thursday, March 12, 2026. The Company will host a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time. Investors and analysts may access the live conference call by dialing 1-844-826-3035 (USA) or 1-412-317-5195 (International). In addition, a live webcast of the conference call will be accessible through the investor relations website here. For those who cannot listen to the live broadcast, an audio replay of the...

Continue reading

Ollie’s Bargain Outlet Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date and Conference Call Information

HARRISBURG, Pa., Feb. 26, 2026 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced that it will report its financial results for the fourth quarter and fiscal year 2025 before the market opens on Thursday, March 12, 2026. Eric van der Valk, President and Chief Executive Officer, and Robert Helm, Executive Vice President and Chief Financial Officer, will host a conference call with the investment community to discuss the financial results and answer questions at 8:30 a.m. Eastern Time on the same day. To access the live conference call, please pre-register here. Registrants will receive a confirmation with dial-in instructions. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.